TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION 15
1.3 OVERVIEW OF EUROPE SURFACE DISINFECTANTS MARKET 15
1.4 LIMITATIONS 17
1.5 MARKETS COVERED 17
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 22
2.4 CURRENCY AND PRICING 22
2.5 DBMR TRIPOD DATA VALIDATION MODEL 23
2.6 COMPOSITION LIFE LINE CURVE 26
2.7 MULTIVARIATE MODELING 27
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 28
2.9 DBMR MARKET POSITION GRID 29
2.10 MARKET END USER COVERAGE GRID 30
2.11 DBMR MARKET CHALLENGE MATRIX 31
2.12 DBMR VENDOR SHARE ANALYSIS 32
2.13 IMPORT-EXPORT DATA 32
2.14 SECONDARY SOURCES 34
2.15 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHT 39
4.1 U.S SURFACE DISINFECTANT ANALYSIS 40
4.2 EPIDEMIOLOGY 41
4.2.1 INCIDENCE 41
4.2.2 TREATMENT RATE 41
4.2.3 MORTALITY RATE 42
4.2.4 PATIENT TREATMENT SUCCESS RATE 42
4.3 INDUSTRIAL INSIGHTS: 43
4.3.1 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES 43
4.3.2 KEY PRICING STRATEGIES 43
4.3.2.1 PRICES OF RAW MATERIALS: 43
4.3.2.2 FLUCTUATION IN DEMAND AND SUPPLY 43
4.3.2.3 LEVELS OF DISINFECTION 44
4.3.3 QUALITY: 44
4.3.4 KEY CONSUMER ENROLLMENT STRATEGIES 44
4.3.5 INTERVIEWS WITH DISINFECTION PRODUCT MANUFACTURERS 44
4.3.6 INTERVIEWS WITH INFECTIOUS DISEASE SCIENTISTS 45
4.4 PESTLE ANALYSIS 46
4.4.1 POLITICAL FACTORS 46
4.4.2 ECONOMIC FACTORS 46
4.4.3 SOCIAL FACTORS 46
4.4.4 TECHNOLOGICAL FACTORS 47
4.4.5 LEGAL FACTORS 47
4.4.6 ENVIRONMENTAL FACTORS 47
4.5 PORTERS FIVE FORCES: 48
4.5.1 THREAT OF NEW ENTRANTS: 48
4.5.2 THREAT OF SUBSTITUTES: 48
4.5.3 CUSTOMER BARGAINING POWER: 49
4.5.4 SUPPLIER BARGAINING POWER: 49
4.5.5 INTERNAL COMPETITION (RIVALRY): 49
5 EUROPE SURFACE DISINFECTANT MARKET: REGULATORY FRAMEWORK 51
6 MARKET OVERVIEW 54
6.1 DRIVERS 56
6.1.1 INCREASING DEMAND FROM HEALTHCARE FACILITIES 56
6.1.2 RISE IN OCCURRENCES OF CHRONIC DISORDERS 56
6.1.3 RISING PRODUCT DEMAND POST THE OUTBREAK OF COVID-19 57
6.1.4 SHIFTING CONSUMERS' PREFERENCE TOWARD USE OF BIO-BASED AND NATURE-FRIENDLY DISINFECTANTS 58
6.2 RESTRAINTS 58
6.2.1 LACK OF UNDERSTANDING REGARDING THE USE OF STANDARD DISINFECTION PRACTICES BY END-USERS 58
6.2.2 AVAILABILITY OF ALTERNATIVE PRODUCTS AND TECHNOLOGIES IN THE MARKET 59
6.3 OPPORTUNITIES 60
6.3.1 RISING AWARENESS AMONG A LARGE PERCENTAGE OF POPULATION 60
6.3.2 INCREASING FOCUS ON RESEARCH AND DEVELOPMENT (R&D) INITIATIVES 60
6.4 CHALLENGES 61
6.4.1 ENVIRONMENTAL & HEALTH HAZARDS ASSOCIATED WITH THE USE OF DISINFECTANTS 61
6.4.2 HIGHER PRICE OF CHEMICAL-BASED SURFACE DISINFECTANTS COMPARED TO BIO-BASED DISINFECTANTS 62

7 EUROPE SURFACE DISINFECTANTS MARKET, COMPOSITION 63
7.1 OVERVIEW 64
7.2 ALCOHOLS 65
7.3 CHLORINE 65
7.4 QUATENARY AMMONIUM 66
7.5 ALDEHYDES 67
7.6 PEROXIDES 67
7.7 BIO DISINFECTANTS 68
8 EUROPE SURFACE DISINFECTANTS MARKET, BY TYPE 69
8.1 OVERVIEW 70
8.2 LIQUID 71
8.3 WIPES 72
8.4 SPRAYS 72
9 EUROPE SURFACE DISINFECTANTS MARKET, BY APPLICATION 74
9.1 OVERVIEW 75
9.2 SURFACE DISINFECTION 76
9.3 INSTRUMENT DISINFECTION 76
9.4 OTHER APPLICATIONS 77
10 EUROPE SURFACE DISINFECTANTS MARKET, END USER 78
10.1 OVERVIEW 79
10.2 HOSPITALS 80
10.3 DIAGNOSTIC AND RESEARCH LABORATORIES 80
10.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 81
10.5 FOOD & BEVERAGES 82
10.6 RESIDENTIAL 83
11 EUROPE SURFACE DISINFECTANTS MARKET, BY REGION 84
11.1 EUROPE 85
11.1.1 GERMANY 91
11.1.2 U.K. 93
11.1.3 FRANCE 95
11.1.4 ITALY 97
11.1.5 SPAIN 99
11.1.6 RUSSIA 101
11.1.7 NETHERLANDS 103
11.1.8 SWITZERLAND 105
11.1.9 BELGIUM 107
11.1.10 TURKEY 109
11.1.11 REST OF EUROPE 111
12 EUROPE SURFACE DISINFECTANT MARKET: COMPANY LANDSCAPE 112
12.1 COMPANY SHARE ANALYSIS: EUROPE 112
12.1.1 COLLABORATION 113
12.1.2 PRODUCT LAUNCHES 113
12.1.3 PARTNERSHIP 113
12.1.4 EVENT 114
13 SWOT ANALYSIS 115
14 COMPANY PROFILES 116
14.1 THE CLOROX COMPANY 116
14.1.1 COMPANY SNAPSHOT 116
14.1.2 REVENUE ANALYSIS 116
14.1.3 COMPANY SHARE ANALYSIS 117
14.1.4 PRODUCT PORTFOLIO 117
14.1.5 RECENT UPDATE 118
14.2 PAUL HARTMANN AG 119
14.2.1 COMPANY SNAPSHOT 119
14.2.2 REVENUE ANALYSIS 119
14.2.3 COMPANY SHARE ANALYSIS 120
14.2.4 PRODUCT PORTFOLIO 120
14.2.5 RECENT UPDATES 121
14.3 PROCTER & GAMBLE 122
14.3.1 COMPANY SNAPSHOT 122
14.3.2 REVENUE ANALYSIS 122
14.3.3 COMPANY SHARE ANALYSIS 123
14.3.4 PRODUCT PORTFOLIO 123
14.3.5 RECENT UPDATE 124
14.4 DIVERSEY HOLDINGS LTD. 125
14.4.1 COMPANY SNAPSHOT 125
14.4.2 REVENUE ANALYSIS 126
14.4.3 COMPANY SHARE ANALYSIS 126
14.4.4 PRODUCT PORTFOLIO 127
14.4.5 RECENT UPDATE 128
14.5 RECKITT BENCKISER GROUP PLC. 129
14.5.1 COMPANY SNAPSHOT 129
14.5.2 REVENUE ANALYSIS 129
14.5.3 COMPANY SHARE ANALYSIS 130
14.5.4 PRODUCT PORTFOLIO 130
14.5.5 RECENT UPDATES 131
14.6 BETCO 132
14.6.1 COMPANY SNAPSHOT 132
14.6.2 PRODUCT PORTFOLIO 132
14.6.3 RECENT UPDATE 133
14.7 BRULIN 134
14.7.1 COMPANY SNAPSHOT 134
14.7.2 PRODUCT PORTFOLIO 134
14.7.3 RECENT UPDATE 134
14.8 CARROLLCLEAN 135
14.8.1 COMPANY SNAPSHOT 135
14.8.2 PRODUCT PORTFOLIO 135
14.8.3 RECENT UPDATES 135
14.9 CETYLITE, INC 136
14.9.1 COMPANY SNAPSHOT 136
14.9.2 PRODUCT PORTFOLIO 136
14.9.3 RECENT UPDATE 137
14.10 CONTEC, INC. 138
14.10.1 COMPANY SNAPSHOT 138
14.10.2 PRODUCT PORTFOLIO 138
14.10.3 RECENT UPDATES 139
14.11 ECOLAB 140
14.11.1 COMPANY SNAPSHOT 140
14.11.2 REVENUE ANALYSIS 140
14.11.3 PRODUCT PORTFOLIO 141
14.11.4 RECENT UPDATES 142
14.12 GESCO HEALTHCARE PVT. LTD. 143
14.12.1 COMPANY SNAPSHOT 143
14.12.2 PRODUCT PORTFOLIO 143
14.12.3 RECENT UPDATE 144
14.13 GOJO INDUSTRIES, INC. 145
14.13.1 COMPANY SNAPSHOT 145
14.13.2 PRODUCT PORTFOLIO 145
14.13.3 RECENT UPDATE 146
14.14 KINNOS INC. 147
14.14.1 COMPANY SNAPSHOT 147
14.14.2 PRODUCT PORTFOLIO 147
14.14.3 RECENT UPDATES 148

14.15 MEDALKAN 149
14.15.1 COMPANY SNAPSHOT 149
14.15.2 PRODUCT PORTFOLIO 149
14.15.3 RECENT UPDATES 150
14.16 MEDIVATORS, INC 151
14.16.1 COMPANY SNAPSHOT 151
14.16.2 PRODUCT PORTFOLIO 151
14.16.3 RECENT UPDATE 151
14.17 MEDLINE INSUSTRIES, LP. 152
14.17.1 COMPANY SNAPSHOT 152
14.17.2 PRODUCT PORTFOLIO 152
14.17.3 RECENT UPDATES 153
14.18 METREX RESEARCH, LLC 154
14.18.1 COMPANY SNAPSHOT 154
14.18.2 PRODUCT PORTFOLIO 154
14.18.3 RECENT UPDATES 155
14.19 OXY PHARM 156
14.19.1 COMPANY SNAPSHOT 156
14.19.2 PRODUCT PORTFOLIO 156
14.19.3 RECENT UPDATES 156
14.20 PAL INTERNATIONAL 157
14.20.1 COMPANY SNAPSHOT 157
14.20.2 PRODUCT PORTFOLIO 157
14.20.3 RECENT UPDATES 158
14.21 PDI, INC. 159
14.21.1 COMPANY SNAPSHOT 159
14.21.2 PRODUCT PORTFOLIO 159
14.21.3 RECENT UPDATES 160
14.22 PHARMAX LIMITED 161
14.22.1 COMPANY SNAPSHOT 161
14.22.2 PRODUCT PORTFOLIO 161
14.22.3 RECENT UPDATES 161
14.23 PURPOSEBUILT BRANDS 162
14.23.1 COMPANY SNAPSHOT 162
14.23.2 RECENT UPDATE 163
14.24 RUHOF 164
14.24.1 COMPANY SNAPSHOT 164
14.24.2 PRODUCT PORTFOLIO 164
14.24.3 RECENT UPDATE 165

14.25 S.C. JOHNSON & SON INC. 166
14.25.1 COMPANY SNAPSHOT 166
14.25.2 PRODUCT PORTFOLIO 166
14.25.3 RECENT UPDATES 167
14.26 SPARTAN CHEMICAL COMPANY, INC. 168
14.26.1 COMPANY SNAPSHOT 168
14.26.2 PRODUCT PORTFOLIO 168
14.26.3 RECENT UPDATES 169
14.27 STERIS 170
14.27.1 COMPANY SNAPSHOT 170
14.27.2 REVENUE ANALYSIS 170
14.27.3 PRODUCT PORTFOLIO 171
14.27.4 RECENT UPDATES 172
14.28 WHITELEY 173
14.28.1 COMPANY SNAPSHOT 173
14.28.2 PRODUCT PORTFOLIO 173
14.28.3 RECENT UPDATES 174
14.29 ZEP INC. 175
14.29.1 COMPANY SNAPSHOT 175
14.29.2 PRODUCT PORTFOLIO 175
14.29.3 RECENT UPDATES 176
14.30 3M 177
14.30.1 COMPANY SNAPSHOT 177
14.30.2 REVENUE ANALYSIS 177
14.30.3 PRODUCT PORTFOLIO 178
14.30.4 RECENT UPDATES 179
15 QUESTIONNAIRE 180
16 RELATED REPORTS 183

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.